| 3COH: reference: A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability., Rawson TE, Ruth M, Blackwood E, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Georges GJ, Goller B, Halladay J, Hunsaker T, Kleinheinz T, Krell HW, Li J, Liang J, Limberg A, McNutt A, Moffat J, Phillips G, Ran Y, Safina B, Ultsch M, Walker L, Wiesmann C, Zhang B, Zhou A, Zhu BY, Ruger P, Cochran AG, J Med Chem. 2008 Aug 14;51(15):4465-75. Epub 2008 Jul 17. PMID: 18630890 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).